Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Angeles Garcia Del Barrio

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2018
Reality of the emetogenic level of irinotecanMaria-Angeles Garcia-Del-Barrio, Salvador Martin-Algarra, Azucena Aldaz Pastor
Journal of Cancer Research and Therapeutics|September 23, 2022
Trastuzumab and thyroid dysfunction: An association to be aware ofRodrigo Sánchez-Bayona, Maria Angeles Garcia Del Barrio, Estibaliz Alegre, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 19, 2023
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potentialIan Olver, Rebecca Clark-Snow, Christina H Ruhlmann, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2018
Reality of the emetogenic level of irinotecanMaria-Angeles Garcia-Del-Barrio, Salvador Martin-Algarra, Azucena Aldaz Pastor
Journal of Cancer Research and Therapeutics|September 23, 2022
Trastuzumab and thyroid dysfunction: An association to be aware ofRodrigo Sánchez-Bayona, Maria Angeles Garcia Del Barrio, Estibaliz Alegre, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 19, 2023
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potentialIan Olver, Rebecca Clark-Snow, Christina H Ruhlmann, et al.
Pageof 1